Briefing
Circulating Tumor DNA and Tissue Testing for Pancreatobiliary Tumors.
The study compared mutation concordance between circulating tumor DNA and tissue next-generation sequencing in advanced pancreatobiliary tumors. The abstract does not name a commercial ctDNA assay.
- Design: Evidence level 3
- Assay: Not named in the abstract
JAMA Network OpenPubMed 40938601DOI 10.1001/jamanetworkopen.2025.31373